1. Medtech Insight

Avita’s Recell Heals 98% Of Burns In Pediatric Trial

 
• By Reed Miller

The Recell system of Spray-On Skin Cells combined with mesh autografts healed 98% of burns within four weeks in 23 pediatric patients treated under US FDA-approved compassionate use and continued access programs.

Avita-Recell
Avita's Recell burn therapy • Source: Avita Medical

[Editor's note: Complete historical information on important medical device trial announcements is available from Informa’s MedDeviceTracker. For an archive of previous Medtech Insight articles on medtech clinical trials, visit the Tracking Trials page.]

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from R&D

More from Business